Clinical Trials
40 trialsSecond-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study
First Affiliated Hospital, Sun Yat-Sen University
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs
First Affiliated Hospital, Sun Yat-Sen University
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
AVIATOR2020
Centre Leon Berard
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
Instituto Ecuatoriano de Enfermedades Digestivas
ALT GIST
Australasian Gastro-Intestinal Trials Group
Ripretinib in Chinese Patients With Advanced GIST: a Real World Study
Peking University
Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study
Sichuan Provincial People's Hospital
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach
RenJi Hospital
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy
RenJi Hospital
68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor
Peking Union Medical College Hospital
A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules
The First Affiliated Hospital with Nanjing Medical University
Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin
Zagazig University
Symptom Inventory for Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center
PRIORITY
Asan Medical Center
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial
Cttq
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment
Shanghai Zhongshan Hospital
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment
Sun Yat-sen University
LECSINGST
First Affiliated Hospital Xi'an Jiaotong University
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor
Jiangsu HengRui Medicine Co., Ltd.
the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor
First Affiliated Hospital Xi'an Jiaotong University
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Assaf-Harofeh Medical Center
POETIG
Universität Duisburg-Essen
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
Fondazione del Piemonte per l'Oncologia
Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor
RenJi Hospital
EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs
Unity Health Toronto
A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
Peking University Cancer Hospital & Institute
GIGIST
Assistance Publique Hopitaux De Marseille
Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery
First Affiliated Hospital, Sun Yat-Sen University
A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients
National Health Research Institutes, Taiwan
Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST
Shanghai Zhongshan Hospital
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC
TH-CR-410
Threshold Pharmaceuticals
A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib.
National University Hospital, Singapore
ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
Nanfang Hospital, Southern Medical University
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
National Cancer Institute (NCI)
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Radboud University Medical Center
Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Maisonneuve-Rosemont Hospital